Suxibuzone molecule | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.044.056 |
| Chemical and physical data | |
| Formula | C24H26N2O6 |
| Molar mass | 438.480 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Suxibuzone is ananalgesic used for joint and muscularpain. It is aprodrug of thenon-steroidal anti-inflammatory drug (NSAID)phenylbutazone,[1] and is commonly used in horses.[2]
Suxibuzone is synthesized by the following method:[3]

Phenylbutazone [50-33-9] (1) is hydroxymethylated with formaldehyde giving ~86% 4-butyl-4-(hydroxymethyl)-1,2-diphenylpyrazolidine-3,5-dione [23111-33-3] (2). This is then esterified with succinic anhydride. [108-30-5] (3) to give (4).
Thisdrug article relating to themusculoskeletal system is astub. You can help Wikipedia byadding missing information. |